Diaxonhit SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Diaxonhit SA with three other
pharmaceutical manufacturers in Europe:
sales of 170.23 million Romanian Leu [US$45.48 million]
Santhera Pharmaceuticals Holding AG
(22.90 million Swiss Francs [US$24.65 million]
based in Sweden
(643.70 million Swedish Kronor [US$80.91 million]
During the year ended December of 2017, sales at
Diaxonhit SA were 42.90 million Euro (US$53.42 million).
increase of 54.8%
versus 2016, when the company's sales were 27.72 million Euro.